Sensex, Nifty open higher; Bajaj Finance surges over 6%

Domestic benchmark indices open higher on Friday’s trade. BSE Sensex trader at 75,066.38, higher by 455.27 pts or 0.61 per cent as of 9.27 am; and Nifty 50 traded at 22,782.05, up 133.85 pts or 0.59 per cent.

Domestic benchmark indices open higher on Friday’s trade. BSE Sensex trader at 75,066.38, higher by 455.27 pts or 0.61 per cent as of 9.27 am; and Nifty 50 traded at 22,782.05, up 133.85 pts or 0.59 per cent.

Nifty scaled to a new high at 22,787.

Also read: Day trading guide for May 03, 2024: Intraday supports, resistances for Nifty50 stocksAll sectoral indices except IT traded in green. Nifty IT slipped 0.16 per cent to trade at 33,149.15 as of 9.21 am. Nifty financial services rose over 1 per cent. Nifty bank was up 0.66 per cent at 49,557.50.

Shrikant Chouhan, Head Equity Research, Kotak Securities, said that the market has been witnessing range-bound activity between 22300 and 22800 levels. “However, crossing 22800 will be positive for the market. Below 22500, it would find support at 22400 and 22300 levels. The strategy should be to reduce long positions between 22700 and 22800 levels. Fresh buying is advisable either above 22800, which could lift the index to 23000 levels or if it falls to 22450-22500 levels,” Chouhan stated. 

For bank nifty, he said that the resistance would be at the 49500 and 49800 levels.

Anand James, Chief Market Strategist, Geojit Financial Services, said, “The swing to 22650-700 followed by the consolidation evolved on anticipated lines, thus invalidating the prospects of a potential drop to 22480. This turn of events has the potential of breaking free off the range trading bias which we had outlined at the start of the week. Such a scenario sees Nifty testing 22880-950 or run all the way to 23200. Alternatively, inability to float above 22660-20 region could signal a weak bias, with eyes on 22480-280.”

Stocks to watchMajor stocks that gained on the NSE as of 9.23 am were Bajaj Finance (over 6 per cent), Bajaj Finserv (4.74%), NTPC (2.52%), Shriram Finance (2.11%), and ONGC (1.79%). Meanwhile, Adani Enterprises (-0.87%), Bharti Airtel (-0.44%), Tech Mahindra (-0.42%), HDFC Life (-0.36%), and L& T (-0.33%) were the major laggards.

The major stocks that hit a 52-week high on the NSE include Ajanta Pharma (10.51%), Arrow Green (8.28%), Max Estates (5.37%), DB International (4.96%), Sobha (4.77%), and Cholamandalam Investment (2.95%).

Bajaj Finance stock surged 6.98 per cent on the NSE as of 9.44 am to trade at ₹7,363.20 after RBI lifted the curbs imposed on the company for sanction and disbursal of new loans under two products – ‘eCOM’ and ‘Insta EMI Card’.

Dabur India stock rises 1.28 per cent after its Q4 results, to trade at ₹532.05 as of 9.43 am.

Like (0)
Previous May 7, 2024 4:00 pm
Next May 7, 2024 4:00 pm

Related posts

  • Senhe Shares: Net profit in the first quarter of 2024 was 28.5033 million yuan, a year-on-year increase of 170.64%

    Senhe Shares (301056) disclosed its first quarter report for 2024 on April 26. In the first quarter of 2024, the company achieved total operating income of 184 million yuan, a year-on-year increase of 43.47%; net profit attributable to the parent company was 28.5033 million yuan, a year-on-year increase of 170.64%; non-net profit after deducting 28.3691 million yuan, a year-on-year increase of 171.07%; generated from operating activities Net cash flow was -19.0282 million yuan, compared with 31.0244 million yuan in the same period last year; during the reporting period, Senhe\’s basic earnings per share was 0.1068 yuan, and the weighted average return on net assets was 3.40%.

    free stock signals April 25, 2024
  • Glenmark gets FDA approval for Ophthalmic solution, shares up

    Glenmark Pharmaceuticals Ltd. secured final approval from the United States Food & Drug Administration (FDA) for its Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5%. The company informed that the solution was deemed bioequivalent and therapeutically equivalent to Combigan Ophthalmic Solution, 0.2%|0.5%, produced by AbbVie, Inc. Glenmark Pharmaceuticals Inc., USA will distribute the product in the US.

    free stock signals May 17, 2024
  • Tesla in talks with Reliance to set up EV manufacturing arm in India

    Tesla may be scouting for a local partner to set up its operations in India. Highly placed sources say the US electric vehicles major is in talks with Reliance Industries for a possible joint venture to build the manufacturing facility in the country.

    free stock signals April 19, 2024
  • Buzzing stocks.Stocks that will see action today: May 16, 2024

    Honeywell Automation India Limited (HAIL) on Wednesday appointed Atul Pai as its Managing Director. Pai succeeds Ashish Gaikwad, who is taking on a broader responsibility as India Leader for Industrial Automation, one of Honeywell International Inc’s strategic business groups, the company said in a statement. “Atul brings more than two decades of experience in various regional and global roles across Honeywell and its finance division.

    free stock signals May 16, 2024
  • EaseMyTrip partners with Google Wallet

    EaseMyTrip.com has announced partnership with Google Wallet to integrate its booking necessities into a single wallet.

    free stock signals May 15, 2024
  • Intellect Design’s iGBT powers Jordan Kuwait bank’s digital transformation

    Intellect Design Arena Ltd.’s shares were up by 0.07 per cent after the company reported that its transaction banking specialist, Intellect Global Transaction Banking (iGTB) with Jordan Kuwait Banks implemented a fully integrated Corporate Banking platform. It is powered by eMACH.ai with 50 per cent coverage amongst active transaction banks in the country.

    free stock signals April 23, 2024